Core Insights - The article highlights the investment strategies and achievements of Paul Franke, a seasoned investor with 39 years of trading experience, emphasizing his contrarian stock selection style and the development of a system called "Victory Formation" for identifying stocks based on supply/demand imbalances [1] Group 1: Investment Strategies - Paul Franke suggests using 10% or 20% stop-loss levels on individual stock choices to manage risk effectively [1] - A diversified approach is recommended, advocating for ownership of at least 50 well-positioned stocks to achieve consistent outperformance in the stock market [1] - The "Bottom Fishing Club" articles focus on identifying deep value candidates or stocks that are experiencing significant upward technical momentum reversals [1] Group 2: Analytical Approach - Franke employs daily algorithm analysis of both fundamental and technical data to enhance stock selection [1] - The "Volume Breakout Report" articles discuss positive trend changes that are supported by strong price and volume trading actions, indicating potential investment opportunities [1]

Core Insights - Tilray Brands, Inc. is hosting a series of Independence Day events across its craft beer taprooms in the U.S. to enhance the holiday experience [1] - The events will feature live music, limited-release brews, barbecues, and unique local festivities [1][16] Event Highlights - Atwater Brewery in Detroit is offering a BBQ deal for $15, which includes a cheeseburger or two hot dogs, two sides, and a beer [3] - 10 Barrel Brewing in East Bend, OR, will have food and drink specials, a best-dressed patriotic contest, and fireworks, with all activities free for all ages [4] - Blue Point Brewing Co will host live music and to-go beer specials, with a special event at the Boardy Barn on July 6, featuring a cover charge and various drink specials [6] - Breckenridge Brewery will feature an 80-piece orchestra and fireworks on July 3, with ticket prices ranging from $14 to $475 for VIP tables [8] - Montauk Brewing Company released a limited-edition beer for its anniversary and will offer it throughout the July 4 week [10] - SweetWater Brewing Co will participate in the Peachtree Road Race and host live music and food specials over the weekend [12] - Terrapin Beer Co will have various activities including beer specials, BBQ food trucks, and contests [14] Company Overview - Tilray Brands, Inc. is a leading global lifestyle and consumer packaged goods company with operations in multiple regions including North America, Europe, and Latin America [17] - The company aims to be a transformative force at the intersection of cannabis, beverage, wellness, and entertainment, focusing on creating memorable experiences [17][18]

Core Insights - Breckenridge Distillery has launched its fifth edition of the Collectors Art Series, collaborating with artist Miles Toland for the label design of the new Calvados Cask Finish whiskey [1][7] - The limited release is bottled at 95 proof (47.5% ABV) and features tasting notes of red apples, oak, vanilla, and cinnamon [5][8] - A portion of the proceeds, specifically $5 per bottle, will be donated to Keep RiNo Wild, supporting community creative spaces and educational programs [6] Company Overview - Breckenridge Distillery, founded in 2008, is recognized as the "World's Highest Distillery" and is known for its award-winning blended bourbon whiskey [11][12] - The distillery has received numerous accolades, including multiple awards at the World Whiskies Awards and the San Francisco World Spirits Competition [12][7] - Breckenridge Distillery is a subsidiary of Tilray Brands, Inc., a leading company in the cannabis-lifestyle and consumer packaged goods sector [14]

Tilray Brands, Inc. (TLRY) closed the most recent trading day at $0.40, moving -2.84% from the previous trading session. The stock fell short of the S&P 500, which registered a gain of 0.52% for the day. Meanwhile, the Dow gained 1%, and the Nasdaq, a tech-heavy index, added 0.52%. The company's shares have seen a decrease of 11.24% over the last month, not keeping up with the Medical sector's gain of 3.5% and the S&P 500's gain of 5.95%.Analysts and investors alike will be keeping a close eye on the perfor ...

Core Insights - Montauk Brewing Co. and Faherty have partnered to create a limited-edition summer beer and apparel collection that reflects the essence of coastal living [1][2] - The collaboration celebrates Montauk Brewing's 13th anniversary with a new tropical beer called The Après Surf Beer, featuring pineapple and coconut flavors [2][4] - The partnership aims to enhance community engagement through a beach cleanup event in collaboration with the Eastern Long Island Chapter of Surfrider Foundation [6] Company Overview - Montauk Brewing Company was founded in 2012 and focuses on crafting exceptional brews while promoting a lifestyle of adventure and enjoyment [8] - Tilray Brands, Inc. is a global lifestyle and consumer packaged goods company with a diverse portfolio, including cannabis, beverages, and wellness products [10] - Faherty, established in 2013, is a family-owned brand committed to sustainable craftsmanship and social impact, with over 78 stores nationwide [12]

Core Insights - A new study published by Tilray Medical focuses on the bioavailability of different cannabinoid formulations, specifically comparing Tilray's THC:CBD extract and nabiximols [1][4] Group 1: Study Overview - The study assessed pharmacokinetic parameters and relative bioavailability of two formulations: Tilray THC:CBD extract (10 mg/mL each of THC and CBD) and nabiximols (total dose of 10.8 mg THC and 10 mg CBD) [2] - Conducted with twelve healthy volunteers, the study revealed that the Cmax for THC and CBD was significantly higher for the Tilray extract compared to nabiximols [3] Group 2: Key Findings - The study found that THC and CBD were undetectable 24 hours post-dose, and 11-OH-THC was markedly reduced from its peak [3] - No serious adverse events were reported during the study, indicating a favorable safety profile for the Tilray formulation [3] Group 3: Implications and Future Directions - The findings suggest that the oral administration of Tilray's THC:CBD extract may achieve higher cannabinoid concentrations more quickly than nabiximols, which could have significant implications for therapeutic use [4] - Tilray's Medical Director emphasized the importance of understanding cannabinoid pharmacokinetics to enhance therapeutic outcomes [5]

Core Insights - Tilray Medical has achieved a significant milestone in its European expansion by introducing three new medical cannabis flower varieties in Italy, becoming the first company in the country to receive official authorization from the Italian Ministry of Health for the import and distribution of its proprietary medical cannabis products [1][2]. Group 1: Product Launch and Regulatory Approval - The newly approved Tilray Medical products are now available for therapeutic use in pharmacies across Italy, highlighting the company's commitment to providing high-quality, EU-GMP certified medical cannabis [2]. - The authorization from the Italian Ministry of Health underscores the importance of medical cannabis as a therapeutic option for patients, enhancing their health and well-being [2]. Group 2: Company Background and Market Position - Tilray Medical is dedicated to providing safe and reliable access to a global portfolio of medical cannabis brands, having evolved from one of the first licensed producers in Canada to a leading supplier in Europe with EU-GMP certified production facilities in Portugal and Germany [3]. - The company operates in multiple European countries, including Germany, Italy, Portugal, Poland, and the United Kingdom, reinforcing its leadership in the European medical cannabis market [2]. Group 3: Corporate Mission and Vision - Tilray Brands, Inc. aims to be a leading global lifestyle and consumer packaged goods company, focusing on cannabis, wellness, and entertainment, with a mission to inspire joy and create memorable experiences through its diverse portfolio of over 40 brands [5].

Tilray Launches a Curated Selection of Canadian Cannabis Beverages, Vapes, and Pre-Rolls to Enrich Your Summer Activities TORONTO, June 23, 2025 (GLOBE NEWSWIRE) -- Tilray Brands, Inc. (Nasdaq: TLRY; TSX: TLRY), a global lifestyle and consumer packaged goods company at the forefront of the beverage, cannabis and wellness industries, announces its 2025 summer cannabis collection offered by its wholly-owned licensed cannabis producers, Aphria Inc. and High Park Holdings Ltd. This curated roundup features bold ...

Company Performance - Tilray Brands, Inc. (TLRY) closed at $0.38, reflecting a -9.07% change from the previous day's closing price, which is less than the S&P 500's daily loss of 0.84% [1] - Over the past month, Tilray's shares have decreased by 14.65%, underperforming the S&P 500's gain of 1.44% [1] Upcoming Earnings - The company is expected to report an EPS of -$0.03, indicating a 25% increase from the same quarter last year [2] - Revenue is forecasted to be $254.8 million, representing a 10.84% increase compared to the year-ago quarter [2] Annual Estimates - For the annual period, the Zacks Consensus Estimates predict an EPS of -$1.01 and revenue of $850.75 million, reflecting changes of -206.06% and 0% respectively from the previous year [3] - Recent analyst estimate revisions suggest a positive outlook for the company's near-term business trends [3] Zacks Rank and Industry Performance - The Zacks Rank system, which evaluates estimate changes, currently places Tilray Brands, Inc. at a rank of 3 (Hold) [5] - The Medical - Products industry, part of the Medical sector, has a Zacks Industry Rank of 151, positioning it in the bottom 39% of over 250 industries [6]

Core Viewpoint - Tilray Brands, Inc. announced the approval of a reverse stock split at a ratio of 1-to-10 to 1-to-20, but has paused its implementation to evaluate timing and stock price [1][2]. Financial Structure - In the fiscal quarter ended February 28, 2025, Tilray reduced its total debt by approximately $76 million, resulting in a net debt to trailing twelve-months Adjusted EBITDA of less than 1.0x [3]. - As of the last fiscal quarter, Tilray's cash and marketable securities balance was approximately $250 million, providing financial strength and flexibility for strategic opportunities and acquisitions [3]. Strategic Objectives of Reverse Stock Split - The reverse stock split aims to ensure compliance with Nasdaq listing requirements, align the number of shares with similar companies, attract institutional shareholders, and potentially save up to $1 million annually in costs associated with stockholder meetings [7].